Statistics on Biotechnology Use  
Results by sector of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.056,551,183,323,
%Companies according to biotechnology used: Genetic code,36,46,22,26,
%Companies according to biotechnology used: Functional units,45,51,38,38,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,27,33,21,21,
%Companies according to biotechnology used: Bioprocesses,47,41,48,55,
%Companies according to biotechnology used: Sub-cellular organisms,8,12,8,4,
%Companies according to biotechnology used: Bio-computing,25,33,13,17,
%Companies according to biotechnology used: Nanobiotechnology,13,18,12,5,
%Companies according to biotechnology used: Other,15,16,16,13,
%Company by field(s) of ultimate application of biotechnology use: Human Health,49,65,38,27,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,25,19,13,
%Company by field(s) of ultimate application of biotechnology use: Food products,30,23,31,42,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,20,24,26,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,11,25,11,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,13,19,7,
Personnel in R&D in biotechnology (no. of persons),10.719,5.901,1.572,3.245,
Personnel in R&D in biotechnology (no. of persons): Researchers,6.131,3.640,912,1.579,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.588,2.261,661,1.667,
Personnel in R&D in biotechnology (no. of persons): women,6.040,3.443,844,1.753,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.411,2.087,511,812,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.629,1.356,333,941,
Personnel in R&D in biotechnology (FTE),7.751,4.659,2,980,5,2.111,1,
Personnel in R&D in biotechnology (FTE): Researchers,4.518,1,2.855,6,621,1.041,5,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.232,7,1.803,6,359,5,1.069,6,
Personnel in R&D in biotechnology (FTE): women,4.471,4,2.697,8,549,7,1.223,9,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.562,7,1.637,8,360,6,564,3,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.908,7,1.060,189,1,659,6,
Internal expenditure on R&D (thousands of euros),679.558,446.123,82.011,151.424,
1) By nature of the expense: Current expenses,634.631,412.211,78.386,144.035,
1.1) Remuneration to researchers,228.857,153.206,31.881,43.769,
1.2) Remuneration to technicians and assistants,104.498,61.567,12.726,30.205,
1.3) Other current expenses,301.276,197.437,33.779,70.060,
2) By nature of the expense: Capital expenses,44.927,33.912,3.625,7.389,
2.1) Land and buildings,2.585,2.159,90,337,
2.2) Equipment and instruments,23.569,14.228,3.239,6.101,
2.3) Acquisition of specific R+D software,1.392,709,128,555,
2.4) Otros productos de propiedad intelectual específicos para I+D,17.381,16.817,168,396,
1) By origin of the funds: National funds,556.297,336.896,71.496,147.904,
1.1) Own funds,387.010,240.941,42.317,103.752,
1.2) From companies,86.025,41.093,17.175,27.757,
1.3) Public Administration funds,74.764,49.704,11.115,13.944,
1.4) From Universities,408,340,2,66,
1.5) From non profit private institutions,8.090,4.818,887,2.385,
1) By origin of the funds: Foreign funds,123.262,109.227,10.514,3.520,
2.1) From EU programmes,25.125,14.287,7.967,2.871,
2.2) Other foreign funds,98.137,94.940,2.547,649,
Purchase of R&D services in biotechnology (thousands of euros),147.558,104.940,19.473,23.146,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,76.875,54.648,12.216,10.011,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,70.683,50.292,7.256,13.135,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,49,59,45,32,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,14,11,20,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,13,25,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,13,12,21,10,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,18,20,24,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,18,21,19,11,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,17,16,21,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,40,39,33,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,51,56,52,44,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,17,22,18,
% Companies that have requested biotechnology patents,16,23,9,6,
Number of patents requested,746,539,142,65,
% Companies with income of an international origin related to biotechnological activities,23,3,33,8,11,6,12,
% Turnover representing income of an international origin related to biotechnological activities,1,2,14,5,0,0,7,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,60,4,66,6,74,8,24,7,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,39,6,33,4,25,3,75,3,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,80,9,78,70,6,98,2,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,17,8,21,3,0,3,1,3,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,3,0,6,29,0,6,
% Income of an international origin related with activities according to the classification: Other,0,1,0,1,0,0,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute